Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ARX | hg38_v1_chrX_-_25015924_25016002 | -0.24 | 1.8e-01 | Click! |
ALX1 | hg38_v1_chr12_+_85280199_85280237 | -0.02 | 9.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_195583931 Show fit | 4.85 |
ENST00000343267.8
ENST00000421243.5 ENST00000453131.1 |
apolipoprotein D |
|
chr14_-_94770102 Show fit | 3.39 |
ENST00000238558.5
|
goosecoid homeobox |
|
chr2_-_218010202 Show fit | 3.30 |
ENST00000646520.1
|
tensin 1 |
|
chr10_-_29634964 Show fit | 3.17 |
ENST00000375398.6
ENST00000355867.8 |
supervillin |
|
chr1_-_151175966 Show fit | 2.71 |
ENST00000441701.1
ENST00000295314.9 |
tropomodulin 4 |
|
chr6_+_121437378 Show fit | 2.38 |
ENST00000650427.1
ENST00000647564.1 |
gap junction protein alpha 1 |
|
chr1_-_91906280 Show fit | 2.28 |
ENST00000370399.6
|
transforming growth factor beta receptor 3 |
|
chr1_+_170663134 Show fit | 2.23 |
ENST00000367760.7
|
paired related homeobox 1 |
|
chr1_-_178869272 Show fit | 2.21 |
ENST00000444255.1
|
angiopoietin like 1 |
|
chr1_-_178871022 Show fit | 2.00 |
ENST00000367629.1
|
angiopoietin like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 3.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.0 | 3.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 3.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 2.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 2.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 2.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 2.4 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.5 | 2.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 1.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 4.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 4.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 2.4 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 3.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 3.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 3.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 2.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.8 | 2.3 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.4 | 2.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 6.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 5.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 4.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 3.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 1.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |